Giant Cell Arteritis Diagnosis and Evaluation
Clinical Evaluation
- The American College of Rheumatology recommends assessing for key symptoms associated with GCA diagnosis, including jaw claudication (positive LR 4.90) and limb claudication (positive LR 6.01), in patients with suspected GCA 1, 2
- Temporal artery thickening (positive LR 4.70), temporal artery loss of pulse (positive LR 3.25), and temporal tenderness (positive LR 3.14) are important signs to evaluate in patients with suspected GCA 1, 2
- Scalp tenderness, although less informative, should also be assessed in patients with suspected GCA 3
Laboratory Testing
- Inflammatory markers, such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), should be obtained in patients with suspected GCA, as their absence can argue against GCA (negative LR 0.18 for ESR >40 mm/h and negative LR 0.38 for CRP >2.5 mg/dL) 1, 2
- A complete blood count with platelet count should also be performed, as thrombocytosis >400 × 10³/μL supports GCA (positive LR 3.75) 1, 2
Diagnostic Procedures
- Temporal artery biopsy is conditionally recommended over temporal artery ultrasound for diagnosing GCA, and should be performed within 2 weeks of starting glucocorticoids to maximize detection 4
- Vascular imaging, such as ultrasound, MRI, CT, or PET, should be performed in all newly diagnosed GCA patients to evaluate large vessel involvement, and in patients with negative temporal artery biopsy but high clinical suspicion 4
Important Considerations
- No single clinical or laboratory feature is sufficient to rule in or rule out GCA; additional investigations are required, according to the American College of Rheumatology 3, 1
- Age >70 years increases the likelihood of GCA, while absence of this feature decreases the likelihood (negative LR 0.48) 1, 2
Diagnosing Giant Cell Arteritis
Clinical Diagnosis and Investigation
- The American College of Rheumatology explicitly states that their 1990 classification criteria should not be used for clinical diagnosis in individual patients, as they were designed for research classification, not diagnostic decision-making 5, 6
- Clinical features such as jaw claudication, limb claudication, temporal artery thickening, temporal artery loss of pulse, ESR >100 mm/h, and platelet count >400 × 10³/μL have moderate positive likelihood ratios, but are not strong enough to confirm GCA when taken alone or in combination 5, 6, 7
- The combination of high-yield symptoms and signs, including jaw or limb claudication, temporal artery abnormalities, and age >70 years, can be used to assess clinical probability 5, 7
Diagnostic Testing
- Both ESR and CRP should be obtained as they provide complementary information, with normal ESR (<40 mm/h) and normal CRP (<2.5 mg/dL) having negative likelihood ratios that argue against GCA 5, 6, 7
- Temporal artery biopsy is the gold standard for diagnosis, but has imperfect sensitivity due to the focal and segmental nature of inflammation, and vascular imaging (ultrasound, MRI, CT, or PET) can be used to evaluate for large vessel involvement 5
Treatment
- The American College of Rheumatology recommends starting immediate high-dose glucocorticoids (40-60 mg/day prednisone-equivalent) if clinical suspicion is reasonable based on the combination of features, and proceeding with confirmatory testing 5, 6
Diagnostic Likelihood Ratios for Giant Cell Arteritis (GCA)
Laboratory Inflammatory Markers
- In adults evaluated for GCA, an erythrocyte sedimentation rate (ESR) > 40 mm/h yields a negative likelihood ratio of 0.18, meaning a normal ESR essentially rules out the disease. 8
- In the same population, a C‑reactive protein (CRP) level > 2.5 mg/dL provides a positive likelihood ratio of 4.5, while a normal CRP gives a negative likelihood ratio of 0.38. 8
- An ESR > 100 mm/h increases the probability of GCA with a positive likelihood ratio of 3.11. 8
Hematologic Findings
- Platelet counts exceeding 400 × 10³/µL are associated with a positive likelihood ratio of 3.75 for GCA. 8
- Anemia is observed in approximately 87 % of patients with GCA, indicating a strong association with the disease. 8